(NaturalNews) A substudy of the PROTEUS trial found that 63% of men who received the hormone therapy apalutamide plus androgen-deprivation therapy before and after …
PROTEUS Substudy Reports 63% of Prostate Cancer Patients Avoid Recurrence With Combination Therapy
Estimated read time
1 min read
You May Also Like
More From Author
Poll Finds Half of Americans Skipping Meals as Grocery Prices Rise
October 29, 2026
Lawsuit Seeks to Block ICE Policy Withholding Detainee Locations
October 29, 2026
